Topical Pain Relief Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

Topical Pain Relief Market – Report Overview

Pacific Business Consulting’s “Topical Pain Relief Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Topical Pain Relief market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

The Topical Pain Relief market, valued at over US$ 9.0 Billion in 2022, is poised for a Compound Annual Growth Rate (CAGR) surpassing 5.0% from 2023 to 2030, potentially reaching beyond US$ 14.0 Billion by 2030.

The growth of the market is primarily fueled by the prevalence of osteoarthritis, diabetic neuropathy, and other bone-related disorders causing pain. Factors such as an aging population, frequent joint stress, joint injuries, obesity, metabolic diseases, accidental injuries, genetic disorders, and bone abnormalities contribute to the rising demand for pain relief solutions. Osteoarthritis alone affects over 32.5 million adult Americans, as reported by the Centers for Disease Control and Prevention, making it the most common joint ailment in the country. Post-pandemic, a shift towards adopting healthy habits and engaging in sports activities and exercise has led to an increased occurrence of acute sports injuries, driving the widespread use of sprays with cooling modalities for relief.

Historically, the development of topical pain relief medications involves continuous research and development efforts, focusing on creating novel formulations, optimizing bioavailability, and improving delivery systems. With a surge in chronic diseases and the growing preference for topical pain relief, the global market is anticipated to experience a CAGR of over 5.0% by 2030.

The aging population is a significant driver for pain management solutions due to the prevalence of chronic pain disorders among the elderly. The high demand for topical pain relief is evident in conditions such as arthritis, back pain, and muscle pain.

Topical products offer a convenient and targeted pain relief option, preferred by many consumers over invasive alternatives. Ongoing research and development lead to formulation improvements, enhancing the effectiveness and safety of topical pain relief solutions.

In a competitive industry, numerous pharmaceutical and healthcare companies provide various topical pain relief medicines. Regulatory licenses and adherence to safety regulations are crucial factors influencing product accessibility and customer confidence.

The market is driven by the rising geriatric population experiencing chronic or acute pain, along with an increasing incidence of chronic diseases. The adoption of topical pain relief is propelled by factors such as the prevalence of arthritis, other bone-related disorders, and the growing engagement in sports activities leading to accidental injuries.

Manufacturers have opportunities to develop technologically advanced products, such as one-shot technology in sprays, to enhance treatment efficacy and safety, addressing the evolving needs of consumers.

While topical remedies provide effective relief for many, certain severe or chronic pain disorders may require systemic treatments. Oral painkillers, in the form of pills or capsules, remain widely used and are often the primary option for many patients.

Key players in the Topical Pain Relief segment, including Bayer Healthcare, Chattem, Inc., Hisamitsu Pharmaceutical Co., Inc., Teva Pharmaceutical Industries Ltd., The Himalayan Drug Co., Troy Healthcare LLC, Advacare Pharma, Glaxosmithkline Plc., Johnson & Johnson, Novartis AG, and Pfizer Inc., are expected to play a pivotal role in shaping the future landscape of Topical Pain Relief technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Topical Pain Relief market. It also delves into the analysis of present and prospective market competition within the global Topical Pain Relief market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Topical Pain Relief market across the 10MM (Ten Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Topical Pain Relief market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

1. Executive Summary: Topical Pain Relief
   • Global Market Outlook: Topical Pain Relief
2. Competitive Intelligence Analysis: Topical Pain Relief
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: Topical Pain Relief
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Key Marketed Products Profile – Major Approved Products: Topical Pain Relief
   • Product Profile
   • Safety and Efficacy
7. Regulatory Landscape
8. Topical Pain Relief: Ten Major Market (10MM) – Market Analysis, By Drug Class
   • Opioids
   • Non-opioids
9. Topical Pain Relief: Ten Major Market (10MM) – Market Analysis, By Formulation
   • Creams & Ointments
   • Gels
   • Sprays
   • Patches
   • Others
10. Topical Pain Relief: Ten Major Market (10MM) – Market Analysis, By Sales Channel
    • Online Channels
    • Hospitals Pharmacies
    • Retail Pharmacies & Drug Stores
    • Others
11. Topical Pain Relief: Ten Major Market (10MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Formulation
      • By Sales Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Formulation
      • By Sales Channel

12. S. Topical Pain Relief – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Formulation
      • By Sales Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Formulation
      • By Sales Channel

13. K. Topical Pain Relief – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Formulation
      • By Sales Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Formulation
      • By Sales Channel

14. Germany Topical Pain Relief – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Formulation
      • By Sales Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Formulation
      • By Sales Channel

15. France Topical Pain Relief – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Formulation
      • By Sales Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Formulation
      • By Sales Channel

16. Italy Topical Pain Relief – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Formulation
      • By Sales Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Formulation
      • By Sales Channel

17. Spain Topical Pain Relief – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Formulation
      • By Sales Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Formulation
      • By Sales Channel

18. Japan Topical Pain Relief – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Formulation
      • By Sales Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Formulation
      • By Sales Channel

19. China Topical Pain Relief – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Formulation
      • By Sales Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Formulation
      • By Sales Channel

20. Australia Topical Pain Relief – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Formulation
      • By Sales Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Formulation
      • By Sales Channel

21. India Topical Pain Relief – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Formulation
      • By Sales Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Formulation
      • By Sales Channel

22. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

23. Assumptions and Acronyms Used
24. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
25. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
26. Copyrights and Disclaimer